Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Clinical trial NCT04488107 · UNKNOWN

Trial details

NCT number: NCT04488107
Sponsor: Ahon Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2019-02-14
Primary completion: 2021-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.